8-K Summary
Business Context and Reporting Period
The filing was submitted by Blue Water Vaccines Inc., not Onconetix, Inc., and is dated January 9, 2023. The company is a Delaware corporation whose common stock trades on Nasdaq under the symbol BWV. The filing reports a Regulation FD disclosure under Item 7.01.
Financial Metrics
This 8-K does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
The company announced that management would present at Biotech Showcase 2023 in San Francisco on January 11, 2023, during the 41st Annual J.P. Morgan Healthcare Conference. The presentation was expected to cover a corporate overview, recent milestones and execution, and pipeline updates. No specific operating or financial changes were disclosed.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide formal financial guidance, forecasts, risk updates, contingencies, or unusual accounting items. The press release was furnished under Regulation FD and was not deemed filed for purposes of Section 18 of the Exchange Act.
Investor Verification Items
- Verify the company identity: the source filing names Blue Water Vaccines Inc., while the request metadata identifies Onconetix, Inc.
- Review Exhibit 99.1 for the complete details of the planned presentation and pipeline updates.
- Do not infer financial performance or guidance from this filing; the text provides no clear financial values.